Login
Home
Charts
Search
Watchlist
Products

Gian Lifecare Ltd

GIANLIFE·BSE
4.74-0.21%Wed, 23 Sept '26 14:54

Gian Lifecare Ltd

GIANLIFE
BSE
4.74
-0.21%
|Wed, 23 Sept '26 14:54
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
5Cr
Close
Close Price
4.74
Industry
Industry
Diagnostic Services
PE
Price To Earnings
PS
Price To Sales
1.30
Revenue
Revenue
4Cr
Rev Gr TTM
Revenue Growth TTM
-62.85%
PAT Gr TTM
PAT Growth TTM
-135.69%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
222452221111
Growth YoY
Revenue Growth YoY%
-37.3-1.6-18.4-25.5196.8-18.5-15.2-58.0-75.9-56.1-66.2-29.6
Expenses
ExpensesCr
222222211111
Operating Profit
Operating ProfitCr
-110230000000
OPM
OPM%
-49.721.014.357.866.111.111.830.2-0.916.1-62.121.4
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-10023000-10-10
Tax
TaxCr
000110000000
PAT
PATCr
-10022000-10-10
Growth YoY
PAT Growth YoY%
18.8425.0-56.5-16.7324.2-65.4-40.0-77.4-128.2-44.4-525.0-71.4
NPM
NPM%
-61.310.78.740.946.34.56.222.0-54.05.8-77.38.9
EPS
EPS
-0.90.30.21.52.10.10.10.3-0.60.1-0.50.1
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
222452221111
Growth YoY
Revenue Growth YoY%
-37.3-1.6-18.4-25.5196.8-18.5-15.2-58.0-75.9-56.1-66.2-29.6
Expenses
ExpensesCr
222222211111
Operating Profit
Operating ProfitCr
-110230000000
OPM
OPM%
-49.721.014.357.866.111.111.830.2-0.916.1-62.121.4
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-10023000-10-10
Tax
TaxCr
000110000000
PAT
PATCr
-10022000-10-10
Growth YoY
PAT Growth YoY%
18.8425.0-56.5-16.7324.2-65.4-40.0-77.4-128.2-44.4-525.0-71.4
NPM
NPM%
-61.310.78.740.946.34.56.222.0-54.05.8-77.38.9
EPS
EPS
-0.90.30.21.52.10.10.10.3-0.60.1-0.50.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
16121374
Growth
Revenue Growth%
-25.110.0-49.5-62.9
Expenses
ExpensesCr
1010764
Operating Profit
Operating ProfitCr
62610
OPM
OPM%
37.815.346.313.8-1.1
Other Income
Other IncomeCr
11100
Interest Expense
Interest ExpenseCr
00010
Depreciation
DepreciationCr
01111
PBT
PBTCr
6260-1
Tax
TaxCr
11200
PAT
PATCr
4140-1
Growth
PAT Growth%
-75.7290.4-100.9-135.7
NPM
NPM%
27.48.931.6-0.6-25.5
EPS
EPS
4.21.04.00.0-0.9
Financial YearMar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
16121374
Growth
Revenue Growth%
-25.110.0-49.5-62.9
Expenses
ExpensesCr
1010764
Operating Profit
Operating ProfitCr
62610
OPM
OPM%
37.815.346.313.8-1.1
Other Income
Other IncomeCr
11100
Interest Expense
Interest ExpenseCr
00010
Depreciation
DepreciationCr
01111
PBT
PBTCr
6260-1
Tax
TaxCr
11200
PAT
PATCr
4140-1
Growth
PAT Growth%
-75.7290.4-100.9-135.7
NPM
NPM%
27.48.931.6-0.6-25.5
EPS
EPS
4.21.04.00.0-0.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
1010101010
Reserves
ReservesCr
45998
Current Liabilities
Current LiabilitiesCr
711101312
Non Current Liabilities
Non Current LiabilitiesCr
22344
Total Liabilities
Total LiabilitiesCr
2328333634
Current Assets
Current AssetsCr
1012131819
Non Current Assets
Non Current AssetsCr
1317191815
Total Assets
Total AssetsCr
2328333634
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
1010101010
Reserves
ReservesCr
45998
Current Liabilities
Current LiabilitiesCr
711101312
Non Current Liabilities
Non Current LiabilitiesCr
22344
Total Liabilities
Total LiabilitiesCr
2328333634
Current Assets
Current AssetsCr
1012131819
Non Current Assets
Non Current AssetsCr
1317191815
Total Assets
Total AssetsCr
2328333634

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
6210
Investing Cash Flow
Investing Cash FlowCr
-4-100
Financing Cash Flow
Financing Cash FlowCr
1000
Net Cash Flow
Net Cash FlowCr
2101
Free Cash Flow
Free Cash FlowCr
5100
CFO To PAT
CFO To PAT%
132.5208.916.8-713.2
CFO To EBITDA
CFO To EBITDA%
96.2121.911.429.0
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
6210
Investing Cash Flow
Investing Cash FlowCr
-4-100
Financing Cash Flow
Financing Cash FlowCr
1000
Net Cash Flow
Net Cash FlowCr
2101
Free Cash Flow
Free Cash FlowCr
5100
CFO To PAT
CFO To PAT%
132.5208.916.8-713.2
CFO To EBITDA
CFO To EBITDA%
96.2121.911.429.0

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
431825185
Price To Earnings
Price To Earnings
9.816.56.1
Price To Sales
Price To Sales
2.71.51.92.71.3
Price To Book
Price To Book
3.11.21.30.90.3
EV To EBITDA
EV To EBITDA
6.69.04.018.2-78.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
79.872.984.177.077.0
OPM
OPM%
37.815.346.313.8-1.1
NPM
NPM%
27.48.931.6-0.6-25.5
ROCE
ROCE%
39.010.325.72.2-2.2
ROE
ROE%
31.27.021.5-0.2-5.1
ROA
ROA%
18.93.812.7-0.1-2.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
431825185
Price To Earnings
Price To Earnings
9.816.56.1
Price To Sales
Price To Sales
2.71.51.92.71.3
Price To Book
Price To Book
3.11.21.30.90.3
EV To EBITDA
EV To EBITDA
6.69.04.018.2-78.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
79.872.984.177.077.0
OPM
OPM%
37.815.346.313.8-1.1
NPM
NPM%
27.48.931.6-0.6-25.5
ROCE
ROCE%
39.010.325.72.2-2.2
ROE
ROE%
31.27.021.5-0.2-5.1
ROA
ROA%
18.93.812.7-0.1-2.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Gian Lifecare Ltd

  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/awbjupibr5a9u4yc1roiucee.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/vcommlipkswe1siulyzwn4k1.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/s4cd4qc4743m8m41kdpoepje.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/jz297e6g7xbrivdh3c8tigty.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/2thauwq16aur2005zd6vd8sw.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/ufhxeyi2x455ymx1y61atfq1.pdf
  • Q2 FY2024 Quarterly Result (Sep 2023, PDF): https://www.stockscans.in/document/purfpxu36vlj2ftlku337x27.pdf
  • Q1 FY2024 Quarterly Result (Jun 2023, PDF): https://www.stockscans.in/document/cusjb4fm00yzzqnpzd38wjzk.pdf
  • Q2 FY2022 Investor Presentation (Sep 2021, PDF): https://www.stockscans.in/document/v7n210f39j5zyu1b9o9m3ry8.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/qljqhk8y3g5c70aqfi9v50zj.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/114jr7xbwflpia0t157dsjat.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/orc7zzws4hgh1txkolo458p1.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/9zpv9g4dlbafkp2ap8rkjiac.pdf